HAP Trading’s ChemoCentryx, Inc. CCXI Stock Holding History

HAP Trading’s Portfolio CCXI Stock Details CCXI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-53,600	Closed	-$268K	–	2513
2022 Q1	$268K	Buy	53,600 +8,600	+19%	+$242K	0.01%	746
2021 Q4	$109K	Buy	45,000 +6,600	+17%	+$232K	﹤0.01%	1210
2021 Q3	$534K	Sell	38,400 -74,500	-66%	-$1.16M	0.02%	662
2021 Q2	$401K	Buy	+112,900	New	+$2.78M	0.01%	725
2020 Q3	–	Sell	-121,700	Closed	-$195K	–	2017
2020 Q2	$195K	Buy	121,700 +20,900	+21%	+$1.14M	0.01%	694
2020 Q1	$363K	Buy	+100,800	New	+$4.28M	0.02%	404

Other funds holding CCXI

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

HAP Trading's CCXI Position: Q2 2022 in Review

HAP Trading sold out of ChemoCentryx, Inc. (CCXI) in Q2 2022, closing a stake of 18,536 shares — an estimated $409K sold.

HAP Trading first reported a position in CCXI in Q2 2021 and held it in 4 quarters. The position peaked at $883K in Q4 2021. 182 funds tracked by Wall St. Rank hold CCXI as of Q2 2022.

HAP Trading reported no remaining ChemoCentryx, Inc. position as of Q2 2022 after selling out during the quarter.
HAP Trading sold 18,536 ChemoCentryx, Inc. shares in Q2 2022, an estimated $409K.
HAP Trading first reported a position in ChemoCentryx, Inc. in Q2 2021 and held it in 4 quarters.
HAP Trading's ChemoCentryx, Inc. position peaked at $883K in Q4 2021.
182 funds tracked by Wall St. Rank held ChemoCentryx, Inc. as of Q2 2022.

Based on HAP Trading's 13F filing for Q2 2022, filed 12 Aug 2022.